Viveve Medical, Inc. (VIVE) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
345 INVERNESS DRIVE SOUTH ENGLEWOOD, CO 80112 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2022 MRQ | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19,162 | 6,523 | 13,308 | 29,523 | 20,730 | 8,086 | |||
| Cash and cash equivalents | 19,162 | 6,523 | 13,308 | 29,523 | 20,730 | 8,086 | |||
| Receivables | 549 | 770 | 1,573 | 5,704 | 6,213 | 2,091 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,472 | 3,254 | 4,861 | 4,119 | 2,390 | 2,687 | |||
| Inventory | 1,472 | 3,254 | 4,861 | 4,119 | 2,390 | 2,687 | |||
| Other undisclosed current assets | 1,055 | 2,296 | 2,447 | 2,558 | 2,741 | 1,066 | |||
| Total current assets: | 22,238 | 12,843 | 22,189 | 41,904 | 32,074 | 13,930 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,554 | 2,759 | 3,046 | 2,916 | 1,303 | 483 | |||
| Long-term investments and receivables | 577 | 833 | 1,216 | 1,843 | 2,500 | ||||
| Long-term investments | 577 | 833 | 1,216 | 1,843 | 2,500 | ||||
| Other noncurrent assets | 1,544 | 195 | 526 | 171 | 202 | 136 | |||
| Total noncurrent assets: | 3,675 | 3,787 | 4,788 | 4,930 | 4,005 | 619 | |||
| TOTAL ASSETS: | 25,913 | 16,630 | 26,977 | 46,834 | 36,079 | 14,549 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,533 | 3,297 | 6,306 | 10,760 | 9,404 | 5,272 | |||
| Accounts payable | 1,480 | 881 | 1,608 | 3,994 | 4,799 | 3,086 | |||
| Accrued liabilities | 3,053 | 2,416 | 4,698 | 6,766 | 4,605 | 2,186 | |||
| Debt | 918 | 1,867 | |||||||
| Total current liabilities: | 4,533 | 4,215 | 6,306 | 10,760 | 9,404 | 7,139 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 5,124 | 4,943 | 3,983 | 30,528 | 28,948 | 7,762 | |||
| Long-term debt, excluding current maturities | 5,124 | 4,943 | 3,983 | 30,528 | 28,948 | 7,762 | |||
| Liabilities, other than long-term debt | 1,190 | 498 | 167 | 634 | 327 | 53 | |||
| Other liabilities | 1,190 | 498 | 167 | 634 | 327 | 53 | |||
| Total noncurrent liabilities: | 6,314 | 5,441 | 4,150 | 31,162 | 29,275 | 7,815 | |||
| Total liabilities: | 10,847 | 9,656 | 10,456 | 41,922 | 38,679 | 14,954 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 15,066 | 6,974 | 16,521 | 4,912 | (2,600) | (405) | |||
| Common stock | 1 | 1 | 5 | 2 | |||||
| Additional paid in capital | 256,918 | 226,800 | 214,431 | 160,292 | 102,979 | 68,216 | |||
| Accumulated deficit | (241,853) | (219,826) | (197,911) | (155,385) | (105,581) | (68,622) | |||
| Other undisclosed equity, attributable to parent | 1 | ||||||||
| Total equity: | 15,066 | 6,974 | 16,521 | 4,912 | (2,600) | (405) | |||
| TOTAL LIABILITIES AND EQUITY: | 25,913 | 16,630 | 26,977 | 46,834 | 36,079 | 14,549 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,426 | 5,479 | 6,567 | 18,517 | 15,288 | 7,141 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 15,288 | 7,141 | |
| Cost of revenue (Cost of Goods and Services Sold) | (5,806) | (5,183) | (5,551) | (11,197) | (7,844) | (4,612) | ||
| Gross profit: | 620 | 296 | 1,016 | 7,320 | 7,444 | 2,529 | ||
| Operating expenses | (22,173) | (18,791) | (31,695) | (52,285) | (41,174) | (21,233) | ||
| Operating loss: | (21,553) | (18,495) | (30,679) | (44,965) | (33,730) | (18,704) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (203) | (289) | (161) | 13 | (60) | (37) | ||
| Interest and debt expense | 358 | (910) | (11,059) | (4,372) | (3,169) | (1,370) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (373) | (1,838) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (21,771) | (21,532) | (41,899) | (49,324) | (36,959) | (20,111) | ||
| Loss from equity method investments | (256) | (383) | (627) | |||||
| Loss from continuing operations: | (22,027) | (21,915) | (42,526) | (49,324) | (36,959) | (20,111) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (22,027) | (21,915) | (42,526) | (49,324) | (36,959) | (20,111) | |
| Net loss: | (22,027) | (21,915) | (42,526) | (49,324) | (36,959) | (20,111) | ||
| Net loss attributable to noncontrolling interest | (657) | |||||||
| Net loss attributable to parent: | (22,027) | (21,915) | (42,526) | (49,981) | (36,959) | (20,111) | ||
| Preferred stock dividends and other adjustments | (4,691) | (4,149) | (380) | |||||
| Net loss available to common stockholders, diluted: | (26,718) | (26,064) | (42,906) | (49,981) | (36,959) | (20,111) | ||
Comprehensive Income ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (22,027) | (21,915) | (42,526) | (49,324) | (36,959) | (20,111) | ||
| Comprehensive loss: | (22,027) | (21,915) | (42,526) | (49,324) | (36,959) | (20,111) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (657) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (22,027) | (21,915) | (42,526) | (49,981) | (36,959) | (20,111) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.